Billiontoone, Inc. $BLLN Stock Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. trimmed its holdings in Billiontoone, Inc. (NASDAQ:BLLN – Free Report) by 35.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,700 shares of the company’s stock after selling 5,423 shares during the period. Vontobel Holding Ltd.’s holdings in Billiontoone were worth $1,032,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in BLLN. Wasatch Advisors LP acquired a new stake in Billiontoone during the first quarter worth approximately $29,179,000. Renaissance Technologies LLC bought a new position in Billiontoone during the 1st quarter worth $4,046,000. Emerald Advisers LLC raised its holdings in Billiontoone by 26.8% in the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after acquiring an additional 50,613 shares in the last quarter. Public Employees Retirement System of Ohio acquired a new position in Billiontoone in the 1st quarter valued at $1,539,000. Finally, Perceptive Advisors LLC lifted its position in shares of Billiontoone by 26.1% during the 1st quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock valued at $7,248,000 after acquiring an additional 19,000 shares during the period.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on BLLN shares. Weiss Ratings lowered Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a report on Thursday, October 8th. Canaccord Genuity Group began coverage on Billiontoone in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 price target on the stock. JPMorgan Chase & Co. dropped their price target on Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a research note on Thursday, August 6th. Zacks Research raised shares of Billiontoone from a “strong sell” rating to a “hold” rating in a research report on Friday, October 2nd. Finally, Wall Street Zen cut shares of Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Seven research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $126.25.

View Our Latest Stock Analysis on Billiontoone

Insider Transactions at Billiontoone

In related news, CTO David Tsao sold 20,000 shares of the business’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $98.77, for a total value of $1,975,400.00. Following the sale, the chief technology officer owned 1,000 shares of the company’s stock, valued at $98,770. The trade was a 95.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the business’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $136.95, for a total transaction of $4,450,875.00. Following the completion of the sale, the chief executive officer directly owned 20,000 shares in the company, valued at approximately $2,739,000. This represents a 61.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 249,025 shares of company stock worth $27,387,892. Company insiders own 50.22% of the company’s stock.

Billiontoone Stock Up 3.0%

NASDAQ:BLLN opened at $101.03 on Tuesday. The firm’s 50 day simple moving average is $101.04 and its 200 day simple moving average is $101.96. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. Billiontoone, Inc. has a one year low of $61.96 and a one year high of $150.44. The company has a market cap of $4.77 billion and a PE ratio of 144.33.

Billiontoone (NASDAQ:BLLN – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. The firm had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. On average, research analysts anticipate that Billiontoone, Inc. will post 0.80 earnings per share for the current year.

Billiontoone Profile

(Free Report)

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.

Recommended Stories

Want to see what other hedge funds are holding BLLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Billiontoone, Inc. (NASDAQ:BLLN – Free Report).

Institutional Ownership by Quarter for Billiontoone (NASDAQ:BLLN)

Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.